Reply to "Dalbavancin for the treatment of severe hidradenitis suppurativa".

Martora, Fabrizio; Ruggiero, Angelo; Potestio, Luca; Battista, Teresa; Megna, Matteo

Martora, Fabrizio; Ruggiero, Angelo; Potestio, Luca; Battista, Teresa; Megna, Matteo.

Afiliação

Martora F; Section of Dermatology-Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Ruggiero A; Section of Dermatology-Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Potestio L; Section of Dermatology-Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Battista T; Section of Dermatology-Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Megna M; Section of Dermatology-Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.

J Eur Acad Dermatol Venereol ; 37(11): e1328-e1329, 2023 11.

Article em En | MEDLINE | ID: mdl-37417387

Assuntos

Hidradenite Supurativa; Humanos; Hidradenite Supurativa/tratamento farmacológico; Teicoplanina; Qualidade de Vida

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa Limite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google